Company intelligence / Profile preview

TAKO

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Tako is an early-stage biotechnology company focused on developing a next-generation drug discovery platform to design and develop novel medicines. The company leverages advanced computational methods and high-throughput screening to identify new therapeutic candidates across various modalities, including small molecules and peptides. Tako's primary focus is on addressing unmet medical needs in oncology and inflammatory diseases. By integrating machine learning with biological insights, the company aims to accelerate the transition from target identification to clinical development.

Therapeutic areas: ImmunologyOncology
Modalities: Small moleculeBiologicPeptides
Industry: Biotech

Beyond the preview

Go deeper on TAKO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAKO.

Explore the full profile